Funding for AI Drug Development Skyrockets in 2021
Published: August 17, 2021
16th August 2021 – Written by Imogen Fitt – Featured on the Science Advisory Board – The market for artificial intelligence (AI) in drug development and clinical trials has seen renewed interest in recent months, with total funding in the industry now reaching $10.7 billion, according to a report published by U.K. market insights firm Signify Research.
Following a slower period in 2019 and 2020 on account of market uncertainty and the COVID-19 global pandemic, the industry has seen an uptick in interest and capital funding for both emerging and late-stage vendors (which often cite oversubscribed rounds).
Click here to continue reading on The Science Advisory Boards website…Share on LinkedIn
AI in Drug Development & Clinical TrialsPublished December 2020.
AI in Drug Development & Clinical Trials
This is a brochure for Signify Research’s 2020 report on the global market for AI in drug development & clinical trials published in December 2020.
Find out more